Miller et al., 2005 - Google Patents
Primate trace amine receptor 1 modulation by the dopamine transporterMiller et al., 2005
View PDF- Document ID
- 653036108551150893
- Author
- Miller G
- Verrico C
- Jassen A
- Konar M
- Yang H
- Panas H
- Bahn M
- Johnson R
- Madras B
- Publication year
- Publication venue
- The Journal of pharmacology and experimental therapeutics
External Links
Snippet
Recently identified trace amine receptors are potential direct targets for drugs of abuse, including amphetamine and 3, 4-methylenedioxymethamphetamine (MDMA). We cloned full- length rhesus monkey trace amine receptor 1 (rhTA 1) that was 96% homologous to human …
- 108010044266 Dopamine Plasma Membrane Transport Proteins 0 title abstract description 25
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Miller et al. | Primate trace amine receptor 1 modulation by the dopamine transporter | |
| Monteiro et al. | SHANK proteins: roles at the synapse and in autism spectrum disorder | |
| US5639652A (en) | DNA encoding a human 5-HT1F receptor and uses thereof | |
| Torres et al. | Plasma membrane monoamine transporters: structure, regulation and function | |
| Voigt et al. | Molecular cloning and characterization of a rat brain cDNA encoding a 5‐hydroxytryptamine1B receptor. | |
| Taylor | Pharmacogenetics of the human beta-adrenergic receptors | |
| Levy et al. | Molecular cloning of a human serotonin receptor (S12) with a pharmacological profile resembling that of the 5-HT1D subtype. | |
| Ting et al. | Molecular and pharmacological evidence for MT1 melatonin receptor subtype in the tail artery of juvenile Wistar rats | |
| Nash et al. | Cloning and characterization of the opossum kidney cell D1 dopamine receptor: expression of identical D1A and D1B dopamine receptor mRNAs in opossum kidney and brain. | |
| De Fusco et al. | The α2B‐adrenergic receptor is mutant in cortical myoclonus and epilepsy | |
| Xu et al. | Identification and characterization of seven new exon 11-associated splice variants of the rat mu opioid receptor gene, OPRM1 | |
| JPH10509139A (en) | Use of receptor potentiators | |
| JP2002514055A (en) | DNA encoding galanin GALR3 receptor and use thereof | |
| Fumagalli et al. | Pharmacological properties and biological functions of the GPR17 receptor, a potential target for neuro-regenerative medicine | |
| AU672768B2 (en) | DNA encoding a human 5-HT-1E receptor and uses thereof | |
| Mizoguchi et al. | Human cystinuria-related transporter: localization and functional characterization | |
| Kitazawa et al. | M3 muscarinic receptors mediate positive inotropic responses in mouse atria: a study with muscarinic receptor knockout mice | |
| Bach et al. | Structure functional expression and spatial distribution of a cloned cDNA encoding a rat 5-HT1D-like receptor | |
| Reed et al. | Discovery of VU6027459: a first-in-class selective and CNS penetrant mGlu7 positive allosteric modulator tool compound | |
| Simmler et al. | The SERT Met172 mouse: An engineered model to elucidate the contributions of serotonin signaling to cocaine action | |
| Espinoza et al. | Neuronal functions and emerging pharmacology of TAAR1 | |
| AU2003255513A1 (en) | Use of pp2a phosphatase modulators in the treatment of mental disorders | |
| Linden et al. | Novel promoter and alternate transcription start site of the human serotonin reuptake transporter in intestinal mucosa | |
| Meltzer et al. | Serotonergic mechanisms in schizophrenia: evolution and current concepts | |
| Tamminga | Partial dopamine agonists and the treatment of psychosis |